SCHEMBL30040980

SCHEMBL30040980

Fc1ccc2c(Cl)nnc(Cl)c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 2/20 0.40
MAPT P10636 2/20 0.40
MAPK1 P28482 1/20 0.40
GOT1 P17174 1/20 0.36
BCKDK O14874 1/20 0.34
ACHE P22303 4/20 0.33
MEN1 O00255 1/20 0.33
GFER P55789 1/20 0.33
KMT2A Q03164 1/20 0.33
KIF11 P52732 1/20 0.33
PARP1 P09874 1/20 0.33
DAO P14920 1/20 0.33
BCHE P06276 2/20 0.33
GRIN1 Q05586 2/20 0.33
GRIN2A Q12879 2/20 0.33
POLB P06746 1/20 0.33
LMNA P02545 1/20 0.33
MPI P34949 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1102314 1.00 ALDH1A1 (0.40) ALDH1A1KDM4EMAPTMAPK1GOT1
SCHEMBL4837981 0.82 ADORA2A (0.41) ALDH1A1MAPTMAPK1MEN1KMT2A
SCHEMBL31146783 0.75 PDE5A (0.42) ALDH1A1MAPTGOT1MEN1KMT2A
SCHEMBL3601771 0.75 PDE5A (0.42) ALDH1A1MAPTGOT1MEN1KMT2A
SCHEMBL31146741 0.74 TDP1 (0.35) GOT1
SCHEMBL587805 0.74 TDP1 (0.35) GOT1
SCHEMBL29496596 0.73 C1S (0.38) ALDH1A1KDM4EMAPTMAPK1ACHE
SCHEMBL2459267 0.71 HTT (0.41) ALDH1A1KDM4EMAPTGOT1ACHE
SCHEMBL29426545 0.71 HTT (0.41) ALDH1A1KDM4EMAPTGOT1ACHE
SCHEMBL30040888 0.71 LMNA (0.44) ALDH1A1KDM4EMAPTMAPK1GOT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119233820-A Azo compounds for the treatment of fibrotic diseases 乔治-奥古斯特-哥廷根公法基金会大学的大学医学院 2024-12-31 CN disclosed
WO-2024227701-A1 PYRIDAZINE COMPOUNDS FOR TREATMENT OF FIBROTIC DISEASES Tietze Chemical Consulting UG (haftungsbeschränkt) (DE) 2024-11-07 WO disclosed
CN-115417856-A Pharmaceutical application of substituted heteroaraliphthalazine derivatives and preparation method thereof 成都奥睿药业有限公司 2022-12-02 CN disclosed